Skip to main content


Latest articles

19-04-2021 | Rheumatology | News | Article

Salt intake may be linked to disease activity, hypertension in RA

Urinary sodium-to-potassium ratio is independently and positively associated with disease activity and hypertension in people with rheumatoid arthritis, Japanese study findings indicate.

16-04-2021 | Rheumatology | News | Article

Real-world data reinforce benefit of optimizing methotrexate before starting biologics

Patients with rheumatoid arthritis who have an inadequate response to initial methotrexate therapy achieve comparable improvements in disease activity with treatment optimization as with biologic DMARD therapy initiation, suggest data from the STRATEGE study.

15-04-2021 | Rheumatology | News | Article

Disease activity linked to impaired glucose metabolism in rheumatoid arthritis

Disease activity has been identified as a significant risk factor for impaired glucose metabolism among patients with rheumatoid arthritis.

14-04-2021 | Rheumatology | Highlight | Article

OPAL Balance supports long-term tofacitinib use for psoriatic arthritis

The final analysis of the OPAL Balance long-term extension study suggests that the JAK inhibitor tofacitinib has a consistent safety profile for up to 48 months in patients with psoriatic arthritis.

13-04-2021 | Rheumatology | News | Article

Sprifermin benefits may be greatest in knee osteoarthritis patients at risk for progression

Findings from two studies suggest that sprifermin has a broadly beneficial impact on joint structure in people with knee osteoarthritis, but symptomatic efficacy may be restricted to specific patient populations.

12-04-2021 | Rheumatology | News | Article

Similar rheumatoid arthritis outcomes with oral vs subcutaneous methotrexate

Real-world study results suggest that patients with rheumatoid arthritis who initiate treatment with oral methotrexate achieve similar disease control to those taking the subcutaneous formulation.

09-04-2021 | Rheumatology | News | Article

Researchers probe link between COVID-19 and autoimmunity

A large US study has evaluated the risk for developing incident rheumatic disease following a positive test for SARS-CoV-2.

08-04-2021 | Rheumatology | News | Article

Risk factors for severe COVID-19 identified in patients with systemic vasculitis

Background glucocorticoid use and comorbid respiratory disease may be risk factors for developing severe COVID-19 among people with systemic vasculitis, researchers report.

07-04-2021 | Rheumatology | News | Article

Network meta-analysis suggests comparable efficacy of JAK inhibitors in rheumatoid arthritis

Findings from a network meta-analysis suggest that the efficacy profile of peficitinib is largely similar to that of other Janus kinase inhibitors in patients with rheumatoid arthritis.

06-04-2021 | Rheumatology | News | Article

Transcriptome signatures may point to adalimumab response in RA

UK researchers have identified a pretreatment transcriptome signature that may be associated with a DAS28 response to adalimumab in people with rheumatoid arthritis.

01-04-2021 | Rheumatology | News | Article

Preserved renal function among indicators of relapse risk in ANCA-associated vasculitis

The likelihood of patients with ANCA-associated vasculitis having a relapse increases if they have anti-proteinase 3 ANCA positivity, cardiovascular involvement, or low creatinine levels at diagnosis, shows a meta-analysis.

31-03-2021 | Rheumatology | News | Article

Most RMD patients have antibody response to COVID-19 vaccination

The majority of patients with rheumatic and musculoskeletal diseases develop detectable anti-SARS-CoV-2 antibodies after receiving their first dose of a messenger mRNA COVID-19 vaccine, US researchers report.

31-03-2021 | Rheumatology | News | Article

Improving RA patients’ cardiorespiratory fitness may reduce mortality rates

Patients with rheumatoid arthritis have an increased risk for death that can be attributed in part to low cardiorespiratory fitness, researchers report.

30-03-2021 | Rheumatology | News | Article

Rituximab use may be a risk factor for severe COVID-19

People with rheumatic and musculoskeletal diseases treated with rituximab may have a higher risk for developing severe COVID-19 than those given other treatments, researchers report.

29-03-2021 | Rheumatology | News | Article

EMA recommends approval of belimumab for lupus nephritis

Click through for more information on this expanded indication

26-03-2021 | Rheumatology | News | Article

COVID-19 vaccines immunogenic in people with rheumatic diseases

mRNA vaccines against SARS-CoV-2 elicit an appropriate immune response without triggering flares in people with chronic inflammatory diseases receiving immunosuppressive therapy, researchers report.

24-03-2021 | Rheumatology | News | Article

‘Reassuring’ early findings on COVID-19 vaccine safety in RMD patients

Findings from an observational study suggest that the safety profile of mRNA COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases is consistent with that seen in the clinical trial populations.

23-03-2021 | Rheumatology | News | Article

Lupus ‘may impact’ COVID-19 prognosis

A French nationwide study has described COVID-19 outcomes in patients with systemic lupus erythematosus.

22-03-2021 | Rheumatology | News | Article

‘Inconclusive’ trial results on statins for rheumatoid arthritis prevention

Findings from the STAPRA trial suggest no protective effect of atorvastatin against the development of rheumatoid arthritis in high-risk individuals.

19-03-2021 | Rheumatology | News | Article

Excess myocardial infarction risk remains high in people with RA

People with rheumatoid arthritis still have a substantial excess risk for acute myocardial infarction relative to the general population even though rates have fallen in both groups in recent years, Canadian research shows.

Image Credits